Bangsberg DR - Search Results

1

Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda.

Thompson V, Medard B, Taseera K, Chakera AJ, Andia I, Emenyonu N, Hunt PW, Martin J, Scherzer R, Weiser SD, Bangsberg DR, Tien PC. Thompson V, et al. Among authors: bangsberg dr. AIDS Res Hum Retroviruses. 2011 Jul;27(7):785-91. doi: 10.1089/aid.2010.0272. Epub 2011 Feb 14. AIDS Res Hum Retroviruses. 2011. PMID: 21128866 Free PMC article.

2

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

3

A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy.

Bangsberg DR, Bronstone A, Hofmann R. Bangsberg DR, et al. AIDS Care. 2002 Feb;14(1):3-15. doi: 10.1080/09540120220097892. AIDS Care. 2002. PMID: 11798401

4

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. Bangsberg DR, et al. AIDS. 2003 Sep 5;17(13):1925-32. doi: 10.1097/00002030-200309050-00011. AIDS. 2003. PMID: 12960825

5

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.

Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R. Weiser S, et al. J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):281-8. doi: 10.1097/00126334-200311010-00004. J Acquir Immune Defic Syndr. 2003. PMID: 14600572

6

Are untimed antiretroviral drug levels useful predictors of adherence behavior?

Liechty CA, Alexander CS, Harrigan PR, Guzman JD, Charlebois ED, Moss AR, Bangsberg DR. Liechty CA, et al. Among authors: bangsberg dr. AIDS. 2004 Jan 2;18(1):127-9. doi: 10.1097/00002030-200401020-00017. AIDS. 2004. PMID: 15090840

7

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. Oyugi JH, et al. Among authors: bangsberg dr. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2. doi: 10.1097/00126334-200408150-00014. J Acquir Immune Defic Syndr. 2004. PMID: 15247564

8

The HIV Epidemic Among Individuals with Mental Illness in the United States.

Weiser SD, Wolfe WR, Bangsberg DR. Weiser SD, et al. Among authors: bangsberg dr. Curr Infect Dis Rep. 2004 Oct;6(5):404-410. doi: 10.1007/s11908-004-0041-2. Curr Infect Dis Rep. 2004. PMID: 15461893

9

Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study.

Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR. Moss AR, et al. Among authors: bangsberg dr. Clin Infect Dis. 2004 Oct 15;39(8):1190-8. doi: 10.1086/424008. Epub 2004 Sep 27. Clin Infect Dis. 2004. PMID: 15486844

10

Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence.

Weiser SD, Guzman D, Riley ED, Clark R, Bangsberg DR. Weiser SD, et al. Among authors: bangsberg dr. HIV Clin Trials. 2004 Sep-Oct;5(5):278-87. doi: 10.1310/LNHD-K1R7-HQP5-HJCQ. HIV Clin Trials. 2004. PMID: 15562368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters